Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Zevra Therapeutics (ZVRA) Shares Repurchased (2021 - 2023)

Historic Shares Repurchased for Zevra Therapeutics (ZVRA) over the last 3 years, with Q1 2023 value amounting to $3.4 million.

  • Zevra Therapeutics' Shares Repurchased fell 2701.67% to $3.4 million in Q1 2023 from the same period last year, while for Dec 2023 it was $3.4 million, marking a year-over-year decrease of 2701.67%. This contributed to the annual value of $3.4 million for FY2023, which is 2701.67% down from last year.
  • Zevra Therapeutics' Shares Repurchased amounted to $3.4 million in Q1 2023, which was down 2701.67% from $4.7 million recorded in Q1 2022.
  • Zevra Therapeutics' 5-year Shares Repurchased high stood at $4.7 million for Q1 2022, and its period low was $2.8 million during Q4 2021.
  • For the 3-year period, Zevra Therapeutics' Shares Repurchased averaged around $3.7 million, with its median value being $3.4 million (2023).
  • Data for Zevra Therapeutics' Shares Repurchased shows a peak YoY increase of 2701.67% (in 2023) and a maximum YoY decrease of 2701.67% (in 2023) over the last 5 years.
  • Quarter analysis of 3 years shows Zevra Therapeutics' Shares Repurchased stood at $2.8 million in 2021, then surged by 67.84% to $4.7 million in 2022, then fell by 27.02% to $3.4 million in 2023.
  • Its Shares Repurchased was $3.4 million in Q1 2023, compared to $4.7 million in Q1 2022 and $2.8 million in Q4 2021.